Table V.
Clinical examples of the nomograms prediction in terms of overall survival modulated in relation to risk factors.
| Age at diagnosis | NO | ECOG 0 | RT Dose ≥ 66 Gy | Interruption RT days ≥ 3 | Death risk at 2 y (%) | |
|---|---|---|---|---|---|---|
| Very Good | 65 | N- | Yes | Yes | No | 2 |
| OS > 90% at 2 y | ||||||
| 65 | N- | No | No | No | 3 | |
| 75 | N- | Yes | Yes | No | 3 | |
| 65 | N- | No | Yes | No | 4 | |
| 65 | N- | Yes | Yes | Yes | 5 | |
| 75 | N- | No | Yes | No | 6 | |
| 65 | N+ | Yes | Yes | No | 7 | |
| 75 | N- | Yes | Yes | Yes | 7 | |
| 65 | N- | No | Yes | Yes | 11 | |
| 75 | N+ | Yes | Yes | No | 11 | |
| Good | 75 | N- | No | Yes | Yes | 15 |
| OS > 75-85% at 2 y | ||||||
| 65 | N+ | No | Yes | No | 16 | |
| 65 | N- | Yes | No | No | 16 | |
| 65 | N+ | Yes | Yes | Yes | 17 | |
| 75 | N+ | No | Yes | No | 21 | |
| 75 | N- | Yes | No | No | 22 | |
| 75 | N+ | Yes | Yes | Yes | 24 | |
| Poor | 65 | N+ | No | Yes | Yes | 33 |
| OS > 50-70% at 2 y | ||||||
| 65 | N- | Yes | No | Yes | 33 | |
| 75 | N- | No | No | No | 39 | |
| 75 | N+ | No | Yes | Yes | 42 | |
| 75 | N- | Yes | No | Yes | 42 | |
| 65 | N+ | Yes | No | No | 43 | |
| 65 | N- | No | No | Yes | 53 | |
| 75 | N+ | Yes | No | No | 53 | |
| Very Poor | 65 | N+ | No | No | No | 63 |
| OS > 15-40% at 2 y | ||||||
| 75 | N- | No | No | Yes | 63 | |
| 65 | N+ | Yes | No | Yes | 66 | |
| 75 | N+ | No | No | No | 72 | |
| 75 | N+ | Yes | No | Yes | 74 | |
| 65 | N+ | No | No | Yes | 82 | |
| 75 | N+ | No | No | Yes | 87 |
OS: overall survival; ECOG PS: Eastern Cooperative Oncology Group Performance Status; RT: radiotherapy. Covariates with a negative impact are in bold.